Search Results

Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.

• Authors : Miura M; Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.; Nishino M

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Programmed Cell Death 1 Receptor* ; Hepacivirus*/Hepacivirus*/Hepacivirus*/drug effects

• Source: PloS one [PLoS One] 2024 May 23; Vol. 19 (5), pp. e0299424. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma

• Authors : Leek, Lindsay V M; Notohardjo, Jessica C L; de Joode, Karlijn ...

Subjects: Adult; Aged; 80 and over

Record details

Sex and Age Impact CD4+ T Cell Susceptibility to HIV In Vitro through Cell Activation Dynamics.

• Authors : Brandt, L.; Angelino, P.; Martinez, R.

Subjects: Female; Humans; Male

• Source: Cells, vol. 12, no. 23, pp. 2689

Record details

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)

• Authors : Ramos-Casals, Manel; Olsson, Peter; Calabrese, C

Subjects: Durvalumab; Immune checkpoint inhibitors; Nivolumab

• Source: Clinical and Experimental Rheumatology. 37:114-122

Record details

Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study.

• Authors : Zucali, PA; Lin, C-C; Carthon, BC ...

Subjects: clinical trials as topic; combination; drug therapyEngland

Record details

PD-1 Blockade Reinvigorates Bone Marrow CD8 + T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

• Authors : Minsuk Kwon; Chang Gon Kim; Hoyoung Lee

Subjects: Adult; Aged; 80 and over

Record details

Factors associated with ocular adverse event after immune checkpoint inhibitor treatment

• Authors : Yong Joon Kim; Jihei Sara Lee; Junwon Lee

Subjects: Adult; Aged; 80 and over

Record details

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

• Authors : Robert Motzer; Boris Alekseev; Sun-Young Rha

Subjects: Adult; Aged; 80 and over

Record details

Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab

• Authors : De Filippi R.; Morabito F.; Santoro A. ...

Subjects: Body mass index; Hodgkin lymphoma; Immune checkpoint inhibitor

Record details

Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab

• Authors : D'Alo' F.;

Subjects: Body mass index; Hodgkin lymphoma; Immune checkpoint inhibitors

Record details